Charité - Universitätsmedizin Berlin, Institut für Mikrobiologie und Hygiene, Dorotheenstr. 96, 10117, Berlin, Germany,
Curr Infect Dis Rep. 2010 Jul;12(4):244-52. doi: 10.1007/s11908-010-0111-6.
Infective endocarditis (IE) is a life-threatening disease associated with high mortality. Conventional microbiologic diagnosis is based mainly on culture-dependent methods that often fail because of previous antibiotic therapy or the involvement of fastidious or slowly growing microorganisms. In recent years, molecular techniques entered the field of routine diagnostics. Amplification-based methods proved useful for detection of microorganisms in heart valve tissue. More recently, they were applied to blood samples from patients with IE. Direct detection of microorganisms in valve specimens by fluorescence in situ hybridization allowed identification of the causative agent and simultaneous visualization of complex microbial communities. These techniques will gain more importance in the near future, provided that procedures are standardized and results are interpreted with caution. With this review, we intend to give an overview of the impact and limitations of molecular techniques for the diagnosis of IE, including a focus on recent developments.
感染性心内膜炎(IE)是一种危及生命的疾病,死亡率高。传统的微生物诊断主要基于基于培养的方法,但由于先前的抗生素治疗或复杂或生长缓慢的微生物的参与,这些方法往往会失败。近年来,分子技术进入了常规诊断领域。基于扩增的方法已被证明可用于检测心脏瓣膜组织中的微生物。最近,它们被应用于 IE 患者的血液样本中。通过荧光原位杂交直接检测瓣膜标本中的微生物,可鉴定病原体并同时可视化复杂的微生物群落。这些技术在不久的将来将变得更加重要,前提是程序标准化且结果谨慎解读。通过这篇综述,我们旨在概述分子技术对 IE 诊断的影响和局限性,包括对最新进展的关注。